Literature DB >> 3793935

Idiopathic membranous glomerulonephritis: aspects of geographical differences.

S Abe, Y Amagasaki, K Konishi, E Kato, S Iyori, H Sakaguchi.   

Abstract

Clinicopathological studies of 89 cases of idiopathic membranous glomerulonephritis was carried out to investigate the clinical and histopathological characteristics of the disease. The results were compared with those of previous published reports to observe whether any difference between Japanese and caucasian patients exists. There were no obvious differences as to main clinical features, although an apparently better prognosis in our data was observed during long term follow up. In renal biopsy findings, especially glomerular capillary wall injuries, the prevalence of advanced electron microscopic stages (stages III and IV) was higher in the Japanese cases. A higher rate of clinical remission was observed in the treated group. It was concluded that Japanese cases had an obviously better prognosis despite having more advanced histological findings than the caucasian patients.

Entities:  

Mesh:

Year:  1986        PMID: 3793935      PMCID: PMC1140761          DOI: 10.1136/jcp.39.11.1193

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

Review 1.  Recent advances in the understanding of the pathogenesis of glomerulonephritis.

Authors:  J S Cameron
Journal:  Nihon Jinzo Gakkai Shi       Date:  1985-07

2.  Membranous glomerulonephritis. Evolution of clinical and pathologic features.

Authors:  M C Gluck; G Gallo; J Lowenstein; D S Baldwin
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

3.  Clinical membranous nephropathy.

Authors:  N P Mallick; C D Short; J Manos
Journal:  Nephron       Date:  1983       Impact factor: 2.847

4.  Corticosteroid therapy is beneficial in adults with idiopathic membranous glomerulopathy.

Authors:  R J Glassock
Journal:  Am J Kidney Dis       Date:  1982-05       Impact factor: 8.860

5.  Membranous nephropathy: the treatment dilemma.

Authors:  J S Cameron
Journal:  Am J Kidney Dis       Date:  1982-05       Impact factor: 8.860

6.  Strong association between idiopathic membranous nephropathy and HLA-DRW3.

Authors:  P T Klouda; J Manos; E J Acheson; P A Dyer; F S Goldby; R Harris; W Lawler; N P Mallick; G Williams
Journal:  Lancet       Date:  1979-10-13       Impact factor: 79.321

7.  Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; E Imbasciati; L Cagnoli; C Pozzi; P Passerini; C Grassi; D Limido; S Pasquali; T Volpini
Journal:  N Engl J Med       Date:  1984-04-12       Impact factor: 91.245

8.  Membranous nephropathy: its relative benignity in women.

Authors:  J Hopper; P A Trew; C G Biava
Journal:  Nephron       Date:  1981       Impact factor: 2.847

9.  Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan.

Authors:  Y Hiki; Y Kobayashi; I Itoh; N Kashiwagi
Journal:  Kidney Int       Date:  1984-06       Impact factor: 10.612

10.  Survival in idiopathic glomerulonephritis.

Authors:  M Nyberg; E Petterson; G Tallqvist; A Pasternack
Journal:  Acta Pathol Microbiol Scand A       Date:  1980-09
View more
  10 in total

Review 1.  Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.

Authors:  Thilo C von Groote; Gabrielle Williams; Eric H Au; Yizhi Chen; Anna T Mathew; Elisabeth M Hodson; David J Tunnicliffe
Journal:  Cochrane Database Syst Rev       Date:  2021-11-15

Review 2.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

Review 3.  Primary membranous nephropathy: an endless story.

Authors:  Ponticelli Claudio
Journal:  J Nephrol       Date:  2022-10-17       Impact factor: 4.393

4.  Lupus-like membranous nephropathy: Is it lupus or not?

Authors:  Ramin Sam; Amit Joshi; Sam James; Kuang-Yu Jen; Firouz Amani; Peter Hart; Melvin M Schwartz
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

5.  Clinical course and outcome of idiopathic membranous nephropathy in Japanese children.

Authors:  H Tsukahara; Y Takahashi; M Yoshimoto; S Hayashi; S Fujisawa; F Suehiro; K Akaishi; Y Nomura; K Morikawa; M Sudo
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

6.  Factors affecting the long-term outcomes of idiopathic membranous nephropathy.

Authors:  Hyuk Huh; Hajeong Lee; Jung Pyo Lee; Dong Ki Kim; Sohee Oh; Yun Kyu Oh; Yon Su Kim; Chun Soo Lim
Journal:  BMC Nephrol       Date:  2017-03-27       Impact factor: 2.388

7.  Idiopathic membranous nephropathy in older patients: Clinical features and outcomes.

Authors:  Ji-Young Choi; Ho Jun Chin; Hajeong Lee; Eun Hui Bae; Tae Ik Chang; Jeong-Hoon Lim; Hee-Yeon Jung; Jang-Hee Cho; Chan-Duck Kim; Yong-Lim Kim; Sun-Hee Park
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

8.  Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.

Authors:  Yun Jung Oh; Seung Hee Yang; Dong Ki Kim; Shin-Wook Kang; Yon Su Kim
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

9.  Chapter 7: Idiopathic membranous nephropathy.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06

Review 10.  Glomerular diseases and cancer: evaluation of underlying malignancy.

Authors:  Antonello Pani; Camillo Porta; Laura Cosmai; Patrizia Melis; Matteo Floris; Doloretta Piras; Maurizio Gallieni; Mitchell Rosner; Claudio Ponticelli
Journal:  J Nephrol       Date:  2015-10-26       Impact factor: 3.902

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.